Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
52.50
+5.77 (12.35%)
At close: Nov 13, 2024, 4:00 PM
53.96
+1.46 (2.78%)
After-hours: Nov 13, 2024, 6:15 PM EST

Avidity Biosciences Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Avidity Biosciences stock have an average target of 63.22, with a low estimate of 45 and a high estimate of 96. The average target predicts an increase of 20.42% from the current stock price of 52.50.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $45 $63.22 $60 $96
Change -14.29% +20.42% +14.29% +82.86%

Analyst Ratings

The average analyst rating for RNA stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 333455
Buy 444444
Hold 000000
Sell 000000
Strong Sell 000000
Total 777899

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$65
Strong Buy Maintains $65 +23.81% Nov 13, 2024
Needham
Needham
Strong Buy
Reiterates
$60
Strong Buy Reiterates $60 +14.29% Nov 13, 2024
Needham
Needham
Strong Buy
Reiterates
$60
Strong Buy Reiterates $60 +14.29% Oct 31, 2024
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$60$65
Strong Buy Maintains $60$65 +23.81% Oct 30, 2024
TD Cowen
TD Cowen
Strong Buy
Maintains
$56$78
Strong Buy Maintains $56$78 +48.57% Oct 21, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
11.41M
from 9.56M
Increased by 19.33%
Revenue Next Year
12.59M
from 11.41M
Increased by 10.35%
EPS This Year
-2.85
from -2.91
EPS Next Year
-3.12
from -2.85
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
2.32M6.79M9.33M9.22M9.56M11.41M12.59M67.15M
Revenue Growth
511.87%192.67%37.41%-1.09%3.64%19.33%10.35%433.42%
EPS
-9.12-2.05-2.85-3.34-2.91-2.85-3.12-3.37
EPS Growth
--------
Forward PE
--------
No. Analysts -----12128
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 22.1M 35.1M 263.2M
Avg 11.4M 12.6M 67.2M
Low n/a n/a 9.8M

Revenue Growth

Revenue Growth 20242025202620272028
High
130.6%
207.4%
1,990.3%
Avg
19.3%
10.4%
433.4%
Low - -
-22.2%

EPS Forecast

EPS 20242025202620272028
High -2.55 -2.26 -1.25
Avg -2.85 -3.12 -3.37
Low -3.30 -4.16 -4.12

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.